Effect of progesterone on hypothalamic oxytocin messenger ribonucleic acid levels in the lactating rat. 1995

A Thomas, and R S Crowley, and J A Amico
Department of Medicine, University of Pittsburgh, School of Medicine, Pennsylvania, USA.

We recently reported that sequential administration of estrogen and progesterone and subsequent withdrawal of progesterone increased the level of hypothalamic oxytocin (OT) messenger RNA (mRNA) in the female rat. Both estrogen priming and progesterone withdrawal are critical components of this regimen. Rats experience this ovarian steroid pattern during certain lactational events such as on days 10-12 of lactation or with interruption of nursing for 48-72 h. In the present study, we used Northern blot and in situ hybridization to determine the association between the steroid exposure and the level of OT mRNA during these lactational conditions. Week 1 lactating rats that had pups removed for 24 and 48 h, but not 12 h, had significantly higher serum estradiol concentrations than animals continuously nursing their pups on a comparable day of lactation (F4, 15 = 6; P < 0.005). Serum progesterone levels declined significantly during the 48 h after litter removal (F4, 15 = 130.5; P < 0.0001). Significant increases in OT mRNA levels were found at 48 h, but not 12 or 24 h, after litter removal (F4, 15 = 4.3; P < 0.02). Implantation of progesterone-filled capsules to compensate for the spontaneous decline in progesterone that occurs with interruption of nursing attenuated this increase in OT mRNA levels. OT mRNA was significantly higher in the hypothalamic paraventricular nuclei (P < 0.0002) and supraoptic nuclei (P < 0.002) of nursing interrupted animals receiving empty vs. progesterone-filled implants. Implantation of day 12 lactating rats with progesterone capsules for 5 days before being killed blunted the increase in OT mRNA that normally occurs on this day of lactation. The data highlight the pivotal role of estrogen priming and progesterone withdrawal in the increased expression of the OT gene during select lactational events.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

A Thomas, and R S Crowley, and J A Amico
December 1985, Endocrinology,
A Thomas, and R S Crowley, and J A Amico
December 1986, Endocrinology,
A Thomas, and R S Crowley, and J A Amico
September 1993, Endocrinology,
A Thomas, and R S Crowley, and J A Amico
August 1988, Molecular endocrinology (Baltimore, Md.),
A Thomas, and R S Crowley, and J A Amico
January 1998, Advances in experimental medicine and biology,
Copied contents to your clipboard!